SpaceX and OpenAI MegaIPOs Raise Market Top Concerns Analysts Suggest Genpact CEO Suggests AI Could Reduce IT Workload and Slow Job Growth Retail Spending Surge Continues Amid Economic Uncertainty Reports National Retail Federation IXICO Contract Wins Signal Strong Revenue Visibility for Current Fiscal Year Nvidia Shares Dip Despite Wave of Analyst PriceTarget Increases ReadytoDrink Cocktail Market Maintains Growth Momentum in 2026 Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development Radware RDWR Q1 2026 Earnings EPS Misses Estimates Yet Shares Gain SDHC Q1 2026 Earnings BottomLine Beat Defies Soft Housing Headwinds Camden National Corporation CAC Q1 2026 Earnings EPS Beat Surprises Amid Regional Banking Headwinds MIAX Q1 2026 Earnings EPS Surpasses Estimates by 98 Amid Stable Operations SUNE Q2 2024 Earnings NarrowerThanExpected Loss Amid Ongoing Restructuring PDF Solutions Surges 339 as Shares Approach Key Resistance Level JetBlue Airways Rebounds 426 to 526 Amid Airline Sector Optimism Smurfit WestRock SW Edges Higher as Support Holds Resistance Test Ahead Janus International Group Inc JBI Notches Slight Gain as Stock Clings to Support Level Generac Holdings GNRC Surges 7 as Energy Resilience Demand Gains Momentum Trumps Grip on a Shrinking Republican Party Implications for Political Stability and Markets EA Q1 2026 Earnings EPS Misses Estimates by 36 Shares Edge Lower Simulations Plus SLP Holds Steady at 1528 Consolidation or Calm Before a Move Wall Street Hits New Highs as AI Rally Takes a Breather German Business Morale Unexpectedly Improves in May Amid Iran War Energy Disruptions Snowflake Boosts Annual Product Revenue Forecast as Enterprise AI Adoption Accelerates Managing Director Uses Everyday Purchases to Instill Financial Literacy in Children Market Update ADTRAN Walmart Snap and Pinterest Attract Investor Attention Morrisons Plans to Close 100 Stores Citing Government PolicyDriven Cost Pressures Eli Lillys NextGeneration Obesity Drug Retatrutide Achieves Primary Endpoint in Pivotal Trial